TABLE 2.

Disease and Treatment Characteristics of Sample at Baseline

	Total (N=304)		Intervention (N = 152)		Control (N = 152)
Sample Characteristics	N	%	N	%	N	%	P Value
Disease Stage
I	106	34.9	52	34.2	54	35.5
II	174	57.2	87	57.2	87	57.2
III	11	3.6	6	3.9	5	3.3
Missing	13	4.3	7	4.6	6	3.9	0.99
Tumor Size
T1/T1B	160	52.6	78	51.3	82	54.0
T2	124	40.8	63	41.4	61	40.1
T3	14	4.6	7	4.6	7	4.6
T4	1	0.3	1	0.7	0	0.0
Missing	5	1.6	3	2.0	2	1.3	0.81
Lymph Node Status
Positive	123	40.5	61	40.1	62	40.8
Negative	176	57.9	88	57.9	88	57.9
Missing	5	1.6	3	2.0	2	1.3	1.00
Chemotherapy
Yes	226	74.3	109	71.7	117	77.0
No	73	24.0	40	26.3	33	21.7
Missing	5	1.6	3	2.0	2	1.3	0.56
Radiation Therapy
Yes	201	66.1	96	63.2	105	69.1
No	103	33.9	56	36.8	47	30.9	0.28
Surgery
Mastectomy	127	41.8	69	45.4	58	38.2
Lumpectomy	172	56.6	80	52.6	92	60.5
Missing	5	1.6	3	2.0	2	1.3	0.49
Tamoxifen
Yes	158	52.0	82	53.9	76	50.0
No	141	46.4	68	44.7	73	48.0
Missing	5	1.6	2	1.3	3	2.0	0.74
Length of Treatment
≤ 3 months	142	46.7	74	48.7	68	44.7
> 3 months	152	50.0	74	48.7	78	51.3
Missing	10	3.3	4	2.6	6	3.9	0.68
Reconstruction
Yes	63	20.7	32	21.0	31	20.4
No	223	73.4	112	73.7	111	73.0
Missing	18	5.9	8	5.3	10	6.6	0.91
Chronic (non-cancer) Health Problems
No	194	63.8	97	63.8	97	63.8
Yes	104	34.2	54	35.5	50	32.9
Missing	6	2.0	1	0.7	5	3.3	0.28